beta

ANCN

Anchiano Therapeutics Ltd.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel.

Market Cap: 16.9 Million

Primary Exchange: NASDAQ

Website: http://www.anchiano.com

Shares Outstanding: 7.36 Million

Float:

Dividend: (%)

Beta: 0.10601095213701

Sector: Health Technology

Industry: Biotechnology

Short Interest ():

Ethical Flags

Longest drawdown: 193 trading days

From: 2019-02-15 To: 2019-11-12

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud